Taking a look at what insiders are doing to gauge the Zimmer Biomet Holdings Inc. (ZBH)’s direction

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zimmer Biomet Holdings Inc. shares valued at $55,870 were sold by VAN ZUILEN WILFRED on Jul 05. At $105.22 per share, VAN ZUILEN WILFRED sold 531 shares. The insider’s holdings dropped to 2,240 shares worth approximately $0.25 million following the completion of this transaction.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Also, Phipps Chad F sold 35,149 shares, netting a total of over 4,287,248 in proceeds. Following the sale of shares at $121.97 each, the insider now holds 41,539 shares.

Before that, Yi Sang had sold 2,800 shares from its account. In a trade valued at $347,599, the President, Asia Pacific traded Zimmer Biomet Holdings Inc. shares for $124.14 each. Upon closing the transaction, the insider’s holdings decreased to 2,800 shares, worth approximately $0.64 million.

As published in a research note from Needham on May 27, 2022, Zimmer Biomet Holdings Inc. [ZBH] has been rated down from a Buy to a Hold. Analysts at Truist downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 01, 2022, Citigroup has decreased its “Buy” rating to a “Neutral” for ZBH.

Analyzing ZBH’s Price Performance

On Wednesday, Zimmer Biomet Holdings Inc. [NYSE: ZBH] plunged -1.40% to $110.20. The stock’s lowest price that day was $110.20, but it reached a high of $113.55 in the same session. During the last five days, there has been a drop of approximately -5.33%. Over the course of the year, Zimmer Biomet Holdings Inc. shares have dropped approximately -10.58%. Shares of the company reached a 52-week high of $135.05 on 04/21/22 and a 52-week low of $100.39 on 07/14/22. A 50-day SMA is recorded $110.85, while a 200-day SMA reached $118.13. Nevertheless, trading volume fell to 1.11 million shares from 0.68 million shares the previous day.

Support And Resistance Levels for Zimmer Biomet Holdings Inc. (ZBH)

According to the 24-hour chart, there is a support level at 109.08, which, if violated, would cause prices to drop to 107.97. In the upper region, resistance lies at 112.43. The next price resistance is at 114.67. RSI (Relative Strength Index) is 46.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.14, which suggests the price will decrease in the coming days. Percent R is at 60.55%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Zimmer Biomet Holdings Inc. subject to short interest?

Stocks of Zimmer Biomet Holdings Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 100000.0 shares to 2.67 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 2.57 million shares. A jump of 3.75% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.27.

Which companies own the most shares of Zimmer Biomet Holdings Inc. (ZBH)?

According to The Vanguard Group, Inc. filings, the company currently owns 22,729,489 shares, which is about 10.83% of the total ZBH shares outstanding. The investor’s shares have appreciated by 452,082 from its previous 13-F filing of 22277407.0 shares. With the completion of the buy transaction, BlackRock Fund Advisors’s stake is now worth $1,174,426,668. T. Rowe Price Associates, Inc. acquire a 13.51% interest valued at $949.37 million while SSgA Funds Management, Inc. sold a -111,399 stake. A total of -1,017,676 shares of Zimmer Biomet Holdings Inc. were sold by JPMorgan Investment Management, I during the quarter, and 863,740 were bought by Capital Research & Management Co. In its current portfolio, American Century Investment Manag holds 5,911,044 shares valued at $628.46 million.

In terms of Zimmer Biomet Holdings Inc. share price expectations, FactSet research, analysts set an average price target of $125.75 in the next 12 months, up nearly 11.84% from the previous closing price of $111.77. Analysts anticipate Zimmer Biomet Holdings Inc. stock to reach $145.00 by 2022, with the lowest price target being $114.00. In spite of this, 26 analysts ranked Zimmer Biomet Holdings Inc. stock as a Hold at the end of 2022. On March 02, 2022, Loop Capital assigned a price target of “a Hold” to the stock and downgraded coverage with a $130.


Please enter your comment!
Please enter your name here